ROCKWELL MEDICAL, INC.
RMTIRockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
Drugs in Pipeline
6
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
SFP
End Stage Renal Disease
Soluble Ferric Pyrophosphate (SFP)
Renal Failure Chronic Requiring Hemodialysis
Soluble Ferric Pyrophosphate in liquid bicarbonate
End Stage Renal Disease
Heparin
End Stage Renal Disease
Soluble Ferric Pyrophosphate
Kidney Failure
Triferic
End Stage Renal Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
SFP | Phase 3 | End Stage Renal Disease | - | - |
Soluble Ferric Pyrophosphate (SFP) | Phase 3 | Renal Failure Chronic Requiring Hemodialysis | - | - |
Soluble Ferric Pyrophosphate in liquid bicarbonate | Phase 2 | End Stage Renal Disease | - | - |
Heparin | Phase 2 | End Stage Renal Disease | - | - |
Soluble Ferric Pyrophosphate | Phase 2 | Kidney Failure | - | - |
Triferic | Phase 2 | End Stage Renal Disease | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)